/ /

Drug Topics Nav

Hospital/Health-System Pharmacy

The Blood Pressure Drugs that are Linked to Lower Mortality
The Blood Pressure Drugs that are Linked to Lower Mortality
April 11, 2018By Tracey Walker
A study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Six Ways to Support Diabetic Patients with Their Treatment Plans
Six Ways to Support Diabetic Patients with Their Treatment Plans
April 03, 2018By Aine Cryts
Here are six ways providers can help patients manage this daunting disease.
Readmission Cost Savings are a Reality with Enhanced Patient Engagement
March 18, 2018By David Calabrese RPh MHP
Reduce readmissions by focusing on better engagement with patients and improving coordination from inpatient to outpatient settings.
Are Virtual Agents Ready to Interact with Your Healthcare Consumers?
February 26, 2018By Tracey Walker
Eye-opening research by NTT DATA Services sheds light on healthcare consumer satisfaction with virtual versus human agents.
How Current Accreditation Approaches Impact Reduction of Hospital Readmissions
February 24, 2018By Patrick Horine
Hospitals are always looking for ways to reduce readmission rates. They may have an unusual ally in a quality control system originally developed in Europe for the manufacturing sector. Read more about it.
How Healthcare Spin-Offs are Affecting the Industry
February 14, 2018By Tracey Walker
John R. Washlick, Buchanan, Ingersoll & Rooney, and expert in healthcare system transactions and market consolidation, talks to Managed Healthcare Executive about healthcare spin-offs, what that means for the future of mergers and acquisitions, and advice for healthcare executives.
Three Ways Healthcare Organizations Can Improve Care Management
February 10, 2018By Tamara Cull
Here are three strategies to navigate toward next-generation care management and increase member engagement in the process
Three Barriers to Biosimilar Adoption
February 09, 2018By Tracey Walker
Understanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
How the Flu’s Severity Will Affect Healthcare Spending
January 25, 2018By Karen Appold
The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy Changes
January 23, 2018By Tracey Walker
How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.